Standard
FDA Clears AI-Powered ‘Neurora’ Tool to Assist in Autism Diagnoses
Federal regulators have granted clearance to a new diagnostic aid designed to support clinicians in the identification of autism in children. The tool, known as Neurora, was developed by Argus Cognitive, Inc., and has been authorized by the Food and Drug Administration to assist in informing clinical decisions regarding autism spectrum disorder (ASD) for children…
